/Investor DB

LifeX Ventures — 2025 Investments

2 investments dated 2025 · listed companies and verified rows first · show all

Curve Biosciencescurvebio.cominOct 2025 · $40M

Curve Bio builds Whole-Body Intelligence models from its Whole-Body Atlas, a molecular map of the body, to power blood tests that monitor organ health in chronic disease patients.

AI & Machine LearningBiotechDigital HealthDallas, US

Nathan Hunkapiller(Founder)inProf. Shan Wang, PhD(Chief Innovation Officer and Scientific Founder)Ritish Patnaik, PhD(Chief Executive Officer)CHUBA OYOLU(Executive Officer)SHAN XIANG WANG(Executive Officer, Director)RITISH PATNAIK(Executive Officer, Director)

PartnerInaki Berenguer· solo GP

Co-investorsFirst Spark Ventures, LlcLuma GroupNZVCCivilization Ventures Management, LlcMintaka

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Pensero AI

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.